- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00990366
Treatment of Biliary Obstruction Using Biliary Stent With or Without Antireflux Valve
October 10, 2011 updated by: Hanna Vihervaara, Turku University Hospital
Biliary obstruction can be relieved by biliary stent.
Ascending infection of biliary passage (cholangitis) causes hospitalization and obstruction of stents.
Reflux of intestinal fluids through a stent is thought to be one of the causes of cholangitis.
Stents with antireflux valves are designed to reduce the reflux from the bowel.
The purpose of the study is to investigate prospectively whether it is possible to reduce the amount of infection and thus obstruction of biliary stent by using a stent with an antireflux valve compared to a normal stent without an antireflux valve.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Turku, Finland, 20520
- Turku University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 18-89
- biliary obstruction in the lower two thirds of the choledochus
Exclusion Criteria:
- allergy to contrast media
- future pancreaticoduodenectomy
- refusal from the study
- previous stent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: biliary stent without an antireflux valve
patients with biliary obstruction who need a biliary stent, selected for the stent without an antireflux valve arm
|
arms are assigned randomly by closed envelope method
|
ACTIVE_COMPARATOR: biliary stent with an antireflux valve
patients with biliary obstruction, who need a biliary stent, selected for the stent with an antireflux valve arm
|
arms are assigned randomly by closed envelope method
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
patency of a biliary stent
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cholangitis
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Paulina Salminen, MD, Turku University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (ACTUAL)
November 1, 2010
Study Completion (ACTUAL)
November 1, 2010
Study Registration Dates
First Submitted
October 5, 2009
First Submitted That Met QC Criteria
October 5, 2009
First Posted (ESTIMATE)
October 6, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
October 12, 2011
Last Update Submitted That Met QC Criteria
October 10, 2011
Last Verified
October 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 58/180/2009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholangitis
-
Medical University of WarsawNational Science Centre, PolandRecruitingPrimary Sclerosing Cholangitis (PSC)Poland
-
Mayo ClinicActive, not recruiting
-
Cascade Pharmaceuticals, IncCovanceCompletedPrimary Sclerosing Cholangitis (PSC)United States
-
Brigham and Women's HospitalCompletedSclerosing CholangitisUnited States
-
RenJi HospitalRecruitingPrimary Sclerosing Cholangitis | IgG4-related Sclerosing CholangitisChina
-
HighTide Biopharma Pty LtdCompletedPrimary Sclerosing Cholangitis (PSC)United States, Canada
-
Intercept PharmaceuticalsCompletedPrimary Sclerosing Cholangitis (PSC)United States, Italy
-
Mirum Pharmaceuticals, Inc.CompletedPrimary Sclerosing Cholangitis (PSC)United States, United Kingdom, Canada
-
Mayo ClinicCompletedPrimary Sclerosing Cholangitis (PSC)United States
-
Gilead SciencesCompletedPrimary Sclerosing Cholangitis (PSC)United States, Belgium, Canada, Germany, United Kingdom, Italy, Spain, Denmark, Netherlands, Sweden
Clinical Trials on Cook´s biliary stent with an antireflux stent, normal biliary stent
-
Azienda USL 1 ImperiesePapa Giovanni XXIII Hospital; Ospedali Riuniti Marche Nord, Pesaro, Italy; NOCSAE... and other collaboratorsCompletedBiliary CancerItaly
-
Taewoong Medical Co., Ltd.CompletedBiliary Stricture | Malignant NeoplasmsKorea, Republic of
-
Jong Taek, LeeTerminatedBiliary Stricture | Malignant NeoplasmsKorea, Republic of
-
Allium, Ltd.WithdrawnMalignant Obstruction of the Common Bile DuctIsrael
-
Chinese University of Hong KongTerminated
-
Indiana UniversityAmerican College of Gastroenterology; American Society for Gastrointestinal...CompletedBile Duct Neoplasms Malignant
-
Helsinki University Central HospitalWithdrawn
-
Yonsei UniversityCompletedMalignant Biliary ObstructionKorea, Republic of
-
Xuzhou Central HospitalCompletedHepatocellular Carcinoma | Cholangiocarcinoma | Gallbladder CarcinomaChina
-
Institut Paoli-CalmettesCompletedMalignant Biliary ObstructionFrance